CLINICAL TRIALS PROFILE FOR NITROPRESS
✉ Email this page to a colleague
All Clinical Trials for NITROPRESS
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00166166 ↗ | Endothelial Hyperpolarization in Humans | Terminated | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | 2002-07-01 | The purpose of this study is to elucidate the role Endothelium-Derived Hyperpolarizing Factor (EDHF) plays in dilating blood vessels and whether it differs between healthy people and those with high cholesterol. A second purpose of the study is to determine the identity of EDHF. |
| NCT00166166 ↗ | Endothelial Hyperpolarization in Humans | Terminated | Emory University | Phase 2 | 2002-07-01 | The purpose of this study is to elucidate the role Endothelium-Derived Hyperpolarizing Factor (EDHF) plays in dilating blood vessels and whether it differs between healthy people and those with high cholesterol. A second purpose of the study is to determine the identity of EDHF. |
| NCT00945256 ↗ | Muscle Perfusion and Protein Metabolism in Elderly | Completed | National Institute on Aging (NIA) | Phase 1 | 2003-05-01 | The purpose of this study was to examine the role skeletal muscle perfusion plays in mediating muscle protein synthesis in healthy older and younger individuals. The investigators hypothesized that normalization of muscle perfusion in older men and women via exercise or infusion of a vasodilator would enhance nutritive flow and skeletal muscle protein synthesis in the elderly similar to that of their younger counterparts. |
| NCT00945256 ↗ | Muscle Perfusion and Protein Metabolism in Elderly | Completed | The University of Texas Medical Branch, Galveston | Phase 1 | 2003-05-01 | The purpose of this study was to examine the role skeletal muscle perfusion plays in mediating muscle protein synthesis in healthy older and younger individuals. The investigators hypothesized that normalization of muscle perfusion in older men and women via exercise or infusion of a vasodilator would enhance nutritive flow and skeletal muscle protein synthesis in the elderly similar to that of their younger counterparts. |
| NCT02164981 ↗ | A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia | Completed | Stanley Medical Research Institute | Phase 2 | 2015-05-01 | The primary objective of this study is to investigate whether a single infusion of intravenous sodium nitroprusside (0.5 μg/kg/min for 4 hours) is superior to placebo (5% dextrose solution) at in treating positive and negative symptoms of schizophrenia |
| NCT02164981 ↗ | A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia | Completed | Massachusetts General Hospital | Phase 2 | 2015-05-01 | The primary objective of this study is to investigate whether a single infusion of intravenous sodium nitroprusside (0.5 μg/kg/min for 4 hours) is superior to placebo (5% dextrose solution) at in treating positive and negative symptoms of schizophrenia |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NITROPRESS
Condition Name
Clinical Trial Locations for NITROPRESS
Trials by Country
Clinical Trial Progress for NITROPRESS
Clinical Trial Phase
Clinical Trial Sponsors for NITROPRESS
Sponsor Name
